Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
NFX-179
i
Other names:
NFX-179, NFX-179 Gel
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
NFlection Therap
Drug class:
MEK inhibitor
Related drugs:
‹
trametinib (330)
selumetinib (106)
binimetinib (68)
mirdametinib (30)
VS-6766 (27)
BAY86-9766 (16)
CI-1040 (15)
HL-085 (12)
AS703026 (5)
CH4987655 (3)
DS03090629 (3)
LNP3794 (3)
IMM-6-415 (2)
AZD8330 (1)
PD98059 (1)
BI 847325 (0)
GDC-0623 (0)
antroquinonol (0)
MEK Inhibitor (0)
MG-D-1509 (0)
PF-07799544 (0)
WX-554 (0)
NSC311152 (0)
SNR1611 (0)
trametinib (330)
selumetinib (106)
binimetinib (68)
mirdametinib (30)
VS-6766 (27)
BAY86-9766 (16)
CI-1040 (15)
HL-085 (12)
AS703026 (5)
CH4987655 (3)
DS03090629 (3)
LNP3794 (3)
IMM-6-415 (2)
AZD8330 (1)
PD98059 (1)
BI 847325 (0)
GDC-0623 (0)
antroquinonol (0)
MEK Inhibitor (0)
MG-D-1509 (0)
PF-07799544 (0)
WX-554 (0)
NSC311152 (0)
SNR1611 (0)
›
Associations
News
Trials
Phase
Status
Apply
Phase
Status
Apply
NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) (NCT05005845)
Phase 2
NFlection Therapeutics, Inc.
NFlection Therapeutics, Inc.
Completed
Phase 2
NFlection Therapeutics, Inc.
Completed
Last update posted :
11/16/2023
Initiation :
09/20/2021
Primary completion :
10/04/2023
Completion :
10/04/2023
NF1
|
NFX-179
NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) (NCT04435665)
Phase 2a
NFlection Therapeutics, Inc.
NFlection Therapeutics, Inc.
Completed
Phase 2a
NFlection Therapeutics, Inc.
Completed
Last update posted :
08/09/2022
Initiation :
08/21/2020
Primary completion :
04/08/2021
Completion :
04/14/2021
NF1
|
NFX-179
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login